Related Experiment Video
Updated: Feb 12, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Short-term Use of Ventricular Assist Device in a Patient With Restrictive Cardiomyopathy: A Case Report
F Rodríguez-Mora1, E M Cantero-Pérez2, C A Rojas-Bermúdez1
1Cardiac Surgery Department, Virgen del Rocío University Hospital, Seville, Spain.
Abstract:
The CentriMag (Levitronix LLC, Waltham, MA, USA) ventricular assist device is a centrifugal pump designed for short-term support in patients with cardiogenic shock. In patients with restrictive physiology, there is some concern about the use of these devices due a very small ventricular cavity. We review the evolution of a 32-year-old woman with restrictive cardiomyopathy, moderate pulmonary hypertension, and severe biventricular systo-diastolic dysfunction in whom a biventricular Centrimag device was implanted due to a progressive clinical worsening.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Data Reporting and Recording
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Cardiomyopathy V: Interprofessional Care

